ARGENX BV
Engineering life-changing immunology solutions for severe autoimmune diseases.
Yleiskatsaus
- 1–4
- Työntekijät
- Tuntematon
- Liikevaihto
- 2022
- Perustettu
Avainpäättäjät
Wim Parys
Strategic Advisor to the R&D Committee
Peter Ulrichts
Chief Scientific Officer
Camilla Sylvest
Non-executive Director
Filip Borgions
Chief Technology Innovation Officer
+23 lisää yhteystietoja Funnelfeedrissä
Kuvaus
argenx is a global immunology company dedicated to engineering life-changing therapeutic antibodies. They operate an advanced antibody innovation ecosystem where pioneering scientists collaborate closely with engineers. This structure accelerates the discovery of novel targets and differentiated the...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Utländsk juridisk person
- ALV-numero
- SE502091854501
Päättäjät
27 yhteystietoa FunnelfeedrissäWim Parys
Strategic Advisor to the R&D Committee
Peter Ulrichts
Chief Scientific Officer
Camilla Sylvest
Non-executive Director
Filip Borgions
Chief Technology Innovation Officer
Karl Gubitz
Chief Financial Officer
Karen Massey
Chief Executive Officer, Executive Director of the Board of Directors
Luc Truyen
Chief Medical Officer
Marc Schorpion
Global Head of Human Resources
Achim Plueckebaum
Global Head of Digital Technologies
Sandrine Piret‑Gerard
Chief Commercialization Officer
Andria Wilk
Global Head of Quality
Steve Krognes
Non-executive Director, Chairperson of the Audit and Compliance Committee, Member of the Remuneration & Nomination Committee
An Vandebosch
Head of Development
Tony Rosenberg
Non-executive Director, Vice Chairperson of the Board
Malini Moorthy
General Counsel
Dr. Pamela M. Klein
Non-executive Director
Dr. Ana Cespedes
Non-executive Director, Chairperson of the Remuneration & Nomination Committee
Hans de Haard
Co-Founder, Strategic Advisor to the R&D Committee
Mary Lynne Hedley
Strategic Advisor to the R&D Committee
Dr. Brian Kotzin
Non-executive Director and Chairperson of the R&D Committee
Tim Van Hauwermeiren
Co-Founder, Non-Independent Non-Executive Director and Chairperson of the Board
David L. Lacey
Strategic Advisor to the R&D Committee
Beth DelGiacco
Corporate Affairs
Muut yhteyshenkilöt
Lynn Elton
Investor Relations (EU)
Erin Murphy
Media Relations
Arjen Lemmen
Corporate Development & Strategy
Alexandra Roy
Investor Relations (US)
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
AAX Biotech AB
5–9 työntekijätResearch-driven biotech advancing antibody therapies via proprietary technology.
ULTRAGENYX EUROPE GMBH
1–4 työntekijätAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Oblique Therapeutics AB (publ)
10–19 työntekijätInnovative biotech developing breakthrough antibodies using the AbiProt platform.
AMICUS THERAPEUTICS LTD
1–4 työntekijätGlobal biotechnology company developing transformative medicines for rare diseases.
Alexion Pharma Nordics AB
10–19 työntekijätPioneering transformative medicines for the global rare disease community.
Selaa lisää
Kysymyksiä yrityksestä ARGENX BV
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo